SE
61
-4
CRM
67
2
MSFT
50
3
ROP
62
3
LRCX
43
-2
LMT
34
2
DOW
44
10
PGR
65
2
ACN
52
3
PEP
48
6
BAC
53
3
STI
14
-17
AON
54
2
LYB
39
2
SYY
53
4
GOOGL
40
-5
AXP
71
2
AA
48
-12
WM
79
3
GOOG
50
-3
SE
61
-4
CRM
67
2
MSFT
50
3
ROP
62
3
LRCX
43
-2
LMT
34
2
DOW
44
10
PGR
65
2
ACN
52
3
PEP
48
6
BAC
53
3
STI
14
-17
AON
54
2
LYB
39
2
SYY
53
4
GOOGL
40
-5
AXP
71
2
AA
48
-12
WM
79
3
GOOG
50
-3
Financhill
Back

Terns Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
42

TERN
Terns Pharmaceuticals

Last Price:
5.79
Seasonality Move:
55.51%
Buy
61

BMRN
Biomarin Pharmaceutical

Last Price:
64.25
Seasonality Move:
12.47%
Sell
42
Terns Pharmaceuticals (TERN) is a Sell

Is Terns Pharmaceuticals a Buy, Sell or Hold?

  • The current Terns Pharmaceuticals [TERN] share price is $5.79. The Score for TERN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • TERN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.26. The Score for BMRN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TERN Stock Price Chart

What is Terns Pharmaceuticals's stock price today?

  • The Terns Pharmaceuticals share price today is $5.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TERN is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

TERN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 33.2 Sell
Chaikin Money Flow: 576337 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.15 - 7.29) Sell
Bollinger Bands (100): (6.68 - 8.98) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.96 Sell
Relative Strength Index (14 RSI): 38.59 Sell
Chaikin Money Flow: 518116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.94 - 69.24) Sell
Bollinger Bands (100): (67.93 - 87.19) Sell

TERN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.03 Sell
20-day SMA: 6.64 Sell
50-day SMA: 7.64 Sell
200-day SMA: 7.14 Sell
8-day EMA: 6.04 Sell
20-day EMA: 6.55 Sell
50-day EMA: 7.18 Sell
200-day EMA: 7.23 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.73 Buy
20-day SMA: 65.69 Sell
50-day SMA: 68.56 Sell
200-day SMA: 81.05 Sell
8-day EMA: 63.9 Buy
20-day EMA: 65.57 Sell
50-day EMA: 69.74 Sell
200-day EMA: 79.39 Sell

Terns Pharmaceuticals Earnings Growth & TERN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.17 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Terns Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):